Tag: Product Recalls

FDA: Class I recall of Merit Medical’s sheath introducer

Editor's Note The Food and Drug Administration (FDA) on March 31 labeled Merit Medical Systems' (South Jordan, Utah) recall of the Prelude Short Sheath Introducer as Class I, the most serious. The recall was issued because of a manufacturing defect that may cause the tip to separate from the sheath…

Read More

By: Judy Mathias
April 7, 2017
Share

FDA: Field corrective action for Medtronic’s Newport HT70, HT70 Plus ventilators

Editor's Note On April 5, the Food and Drug Administration (FDA) announced that Medtronic (Minneapolis) has notified its customers of a field corrective action for all Newport HT70 and Newport HT70 Plus ventilators manufactured since 2010. The field corrective action is being conducted after reports that the ventilator may reset…

Read More

By: Judy Mathias
April 7, 2017
Share

FDA: Class I recall of HeartStart MRx Monitoy/Defibrillator

Editor's Note The Food and Drug Administration (FDA) on March 24 identified the recall of the HeartStart MRx Monitor/Defibrillator by Phillips Healthcare (Amsterdam) as Class I, the most serious. The recall was initiated because of electrical and battery connection issues that may prevent the device from powering up, charging, and…

Read More

By: Judy Mathias
March 27, 2017
Share

FDA: Class I recall of Medtronic implantable drug infusion pumps

Editor's Note The Food and Drug Administration (FDA) on March 14 categorized the recall by Medtronic (Minneapolis) of its SynchroMed II and SynchroMed EL implantable drug infusion pumps as Class I, the most serious. The pumps are being recalled because a software problem may cause unintended delivery of drugs during…

Read More

By: Judy Mathias
March 15, 2017
Share

FDA: Avella recalling injectable products labeled ‘latex free’

Editor's Note The Food and Drug Administration (FDA) on February 24 announced that Avella Specialty Pharmacy of Houston is recalling all unexpired sterile injectable products labeled “latex free” that were produced at Advanced Pharma’s Houston location between September 1, 2016 and February 16, 2017. Avella and Advanced Pharma have been…

Read More

By: Judy Mathias
February 28, 2017
Share

FDA: Class I recall of Zimmer Biomet Comprehensive Reverse Shoulder

Editor's Note The Food and Drug Administration (FDA) has categorized the recall by Zimmer Biomet (Warsaw, Indiana) of its Comprehensive Reverse Shoulder as Class I, the most serious. The recall was issued because the devices are fracturing at a higher rate than is stated in the labeling. Fractures may result…

Read More

By: Judy Mathias
February 21, 2017
Share

Gaps in FDA’s adverse event reporting system allowed power morcellator risks

Editor's Note A Government Accountability Office (GAO) report finds that gaps in the Food and Drug Administration’s (FDA’s) adverse event reporting system allowed the widespread use of laparoscopic power morcellators for years before their risk for spreading cancer became known, according to the February 10 Mass Device. Immediate Congressional action…

Read More

By: Judy Mathias
February 14, 2017
Share

FDA: Class I recall of CareFusion Alaris Syringe Pump

Editor's Note The Food and Drug Administration (FDA) on February 9 classified the recall by CareFusion (San Diego) of its Alaris Syringe Pump (large volume pump), model 8100, and air-in-line (AIL) sensor kits as Class I, the most serious. The recall was issued because of a faulty AIL sensor, which…

Read More

By: Judy Mathias
February 10, 2017
Share

FDA: Class I recall of Bard Halo One Thin-Walled Guiding Sheath

Editor's Note The Food and Drug Administration (FDA) on January 30 classified the recall by Bard Peripheral Vascular Inc (Tempe, Arizona) of its Halo One Thin-Walled Guiding Sheath as Class I, the most serious. The recall was issued because the sheath body may separate from the sheath hub while removing…

Read More

By: Judy Mathias
February 7, 2017
Share

FDA: Hospira recalls one lot of Vancomycin Hydrochloride for Injection

Editor's Note The Food and Drug Administration (FDA) on January 25 announced the recall by Hospira, Inc (Lake Forest, Illinois) of one lot of Vancomycin Hydrochloride for Injection, (USP (NDC: 0409-6510-01, Lot 591053A, Expiry Date 1NOV2017). The recall was initiated because of a confirmed customer report of the presence of…

Read More

By: Judy Mathias
January 25, 2017
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat